{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-303940","form_type":"8-K","ticker":"NOVT","cik":"0001076930","company_name":"NOVANTA INC","filed_at":"2025-12-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.736010+00:00","generated_at":"2026-05-16T15:50:49.819314+00:00","sec_items":["7.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Novanta appoints Alexander Manganiello as General Counsel and Corporate Secretary","bullets":["Appointed Alexander Manganiello as General Counsel and Corporate Secretary effective December 1, 2025.","Prior role: VP, Deputy General Counsel at Vertex Pharmaceuticals (2019-2025).","Previously held senior legal roles at Pfizer Inc. (2004-2019) and practiced at Ropes & Gray.","Holds A.B. Biology from Harvard University and J.D. from Suffolk Law School."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-303940","json":"https://secwatch.observer/filing/0001193125-25-303940.json","markdown":"https://secwatch.observer/filing/0001193125-25-303940.md","text":"https://secwatch.observer/filing/0001193125-25-303940.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1076930/000119312525303940/0001193125-25-303940-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1076930/000119312525303940/novt-20251201.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T15:50:49.819314+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}